Log in to your Inderes Free account to see all free content on this page.
Novonesis
378.50 DKK
-0.42 %
Less than 1K followers
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
-0.42 %
-1.43 %
+1.75 %
-7.18 %
-5.26 %
-18.69 %
+7.77 %
-16.69 %
+922.97 %
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Read moreMarket cap
177.25B DKK
Turnover
195.82M DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.8.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Interim report Q1 2026
Trading by management and close relations of management
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio